The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Sirolimus

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Sirolimus.
Andrzej Jakubowiak
Connection Strength
0.086
Sirolimus
  1. Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study. Lancet Oncol. 2011 Mar; 12(3):263-72.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.